Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028)

This Phase I study evaluated the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine (PCV), via subcutaneous (SC) or intramuscular (IM) administration, in healthy Japanese infants 3 months of age. A total of 133 participants were randomized to receive four do...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Yasunori, Kuroki, Haruo, Hidaka, Hidenobu, Iwai, Kazuyuki, Wan, Keiko, Shirakawa, Masayoshi, Sawata, Miyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Pneumococcal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026902/
https://www.ncbi.nlm.nih.gov/pubmed/36882898
http://dx.doi.org/10.1080/21645515.2023.2180973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026902/
https://www.ncbi.nlm.nih.gov/pubmed/36882898
http://dx.doi.org/10.1080/21645515.2023.2180973

Ejemplares similares